Efficacy of 18F-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma

Erik Mittra, Tarek El-Maghraby, Cesar A. Rodriguez, Andrew Quon, I. Ross McDougall, Sanjiv S. Gambhir, Andrei Iagaru

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Purpose: Only a limited number of studies have evaluated the efficacy of 18F-FDG PET/CT for recurrent cervical carcinoma, which this study seeks to expand upon. Methods: This is a retrospective study of 30 women with cervical carcinoma who had a surveillance PET/CT after initial therapy. Sensitivity, specificity, accuracy, positive predictive value, and negative predictive value were calculated using a 2×2 contingency table with pathology results (76%) or clinical follow-up (24%) as the gold standard. The Wilson score method was used to perform 95% confidence interval estimations. Results: The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of PET/CT for the detection of local recurrence at the primary site were 93, 93, 93, 86, and 96%, respectively. The same values for the detection of distant metastases were 96, 95, 95, 96, and 95%, respectively. Seventy-one percent of the scans performed in symptomatic patients showed true-positive findings. In comparison, 44% of scans performed in asymptomatic patients showed true-positive findings. But, all patients subsequently had a change in their management based on the PET/CT findings such that the effect was notable. The maximum standardized uptake value ranged from 5 to 28 (average: 13±7) in the primary site and 3 to 23 (average: 8±4) in metastases which were significantly different (p=0.04). Conclusion: This study demonstrates favorable efficacy of 18F-FDG PET/CT for identification of residual/recurrent cervical cancer, as well as for localization of distant metastases.

Original languageEnglish (US)
Pages (from-to)1952-1959
Number of pages8
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume36
Issue number12
DOIs
StatePublished - Dec 1 2009
Externally publishedYes

Fingerprint

Fluorodeoxyglucose F18
Neoplasm Metastasis
Carcinoma
Sensitivity and Specificity
Uterine Cervical Neoplasms
Retrospective Studies
Confidence Intervals
Pathology
Recurrence
Therapeutics

Keywords

  • F-FDG
  • Cervical cancer
  • Efficacy
  • PET/CT
  • Restaging

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Efficacy of 18F-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma. / Mittra, Erik; El-Maghraby, Tarek; Rodriguez, Cesar A.; Quon, Andrew; Ross McDougall, I.; Gambhir, Sanjiv S.; Iagaru, Andrei.

In: European Journal of Nuclear Medicine and Molecular Imaging, Vol. 36, No. 12, 01.12.2009, p. 1952-1959.

Research output: Contribution to journalArticle

Mittra, Erik ; El-Maghraby, Tarek ; Rodriguez, Cesar A. ; Quon, Andrew ; Ross McDougall, I. ; Gambhir, Sanjiv S. ; Iagaru, Andrei. / Efficacy of 18F-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma. In: European Journal of Nuclear Medicine and Molecular Imaging. 2009 ; Vol. 36, No. 12. pp. 1952-1959.
@article{94fd557295f2444084475bb78e7a1d72,
title = "Efficacy of 18F-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma",
abstract = "Purpose: Only a limited number of studies have evaluated the efficacy of 18F-FDG PET/CT for recurrent cervical carcinoma, which this study seeks to expand upon. Methods: This is a retrospective study of 30 women with cervical carcinoma who had a surveillance PET/CT after initial therapy. Sensitivity, specificity, accuracy, positive predictive value, and negative predictive value were calculated using a 2×2 contingency table with pathology results (76{\%}) or clinical follow-up (24{\%}) as the gold standard. The Wilson score method was used to perform 95{\%} confidence interval estimations. Results: The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of PET/CT for the detection of local recurrence at the primary site were 93, 93, 93, 86, and 96{\%}, respectively. The same values for the detection of distant metastases were 96, 95, 95, 96, and 95{\%}, respectively. Seventy-one percent of the scans performed in symptomatic patients showed true-positive findings. In comparison, 44{\%} of scans performed in asymptomatic patients showed true-positive findings. But, all patients subsequently had a change in their management based on the PET/CT findings such that the effect was notable. The maximum standardized uptake value ranged from 5 to 28 (average: 13±7) in the primary site and 3 to 23 (average: 8±4) in metastases which were significantly different (p=0.04). Conclusion: This study demonstrates favorable efficacy of 18F-FDG PET/CT for identification of residual/recurrent cervical cancer, as well as for localization of distant metastases.",
keywords = "F-FDG, Cervical cancer, Efficacy, PET/CT, Restaging",
author = "Erik Mittra and Tarek El-Maghraby and Rodriguez, {Cesar A.} and Andrew Quon and {Ross McDougall}, I. and Gambhir, {Sanjiv S.} and Andrei Iagaru",
year = "2009",
month = "12",
day = "1",
doi = "10.1007/s00259-009-1206-x",
language = "English (US)",
volume = "36",
pages = "1952--1959",
journal = "European Journal of Nuclear Medicine and Molecular Imaging",
issn = "1619-7070",
publisher = "Springer Verlag",
number = "12",

}

TY - JOUR

T1 - Efficacy of 18F-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma

AU - Mittra, Erik

AU - El-Maghraby, Tarek

AU - Rodriguez, Cesar A.

AU - Quon, Andrew

AU - Ross McDougall, I.

AU - Gambhir, Sanjiv S.

AU - Iagaru, Andrei

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Purpose: Only a limited number of studies have evaluated the efficacy of 18F-FDG PET/CT for recurrent cervical carcinoma, which this study seeks to expand upon. Methods: This is a retrospective study of 30 women with cervical carcinoma who had a surveillance PET/CT after initial therapy. Sensitivity, specificity, accuracy, positive predictive value, and negative predictive value were calculated using a 2×2 contingency table with pathology results (76%) or clinical follow-up (24%) as the gold standard. The Wilson score method was used to perform 95% confidence interval estimations. Results: The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of PET/CT for the detection of local recurrence at the primary site were 93, 93, 93, 86, and 96%, respectively. The same values for the detection of distant metastases were 96, 95, 95, 96, and 95%, respectively. Seventy-one percent of the scans performed in symptomatic patients showed true-positive findings. In comparison, 44% of scans performed in asymptomatic patients showed true-positive findings. But, all patients subsequently had a change in their management based on the PET/CT findings such that the effect was notable. The maximum standardized uptake value ranged from 5 to 28 (average: 13±7) in the primary site and 3 to 23 (average: 8±4) in metastases which were significantly different (p=0.04). Conclusion: This study demonstrates favorable efficacy of 18F-FDG PET/CT for identification of residual/recurrent cervical cancer, as well as for localization of distant metastases.

AB - Purpose: Only a limited number of studies have evaluated the efficacy of 18F-FDG PET/CT for recurrent cervical carcinoma, which this study seeks to expand upon. Methods: This is a retrospective study of 30 women with cervical carcinoma who had a surveillance PET/CT after initial therapy. Sensitivity, specificity, accuracy, positive predictive value, and negative predictive value were calculated using a 2×2 contingency table with pathology results (76%) or clinical follow-up (24%) as the gold standard. The Wilson score method was used to perform 95% confidence interval estimations. Results: The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of PET/CT for the detection of local recurrence at the primary site were 93, 93, 93, 86, and 96%, respectively. The same values for the detection of distant metastases were 96, 95, 95, 96, and 95%, respectively. Seventy-one percent of the scans performed in symptomatic patients showed true-positive findings. In comparison, 44% of scans performed in asymptomatic patients showed true-positive findings. But, all patients subsequently had a change in their management based on the PET/CT findings such that the effect was notable. The maximum standardized uptake value ranged from 5 to 28 (average: 13±7) in the primary site and 3 to 23 (average: 8±4) in metastases which were significantly different (p=0.04). Conclusion: This study demonstrates favorable efficacy of 18F-FDG PET/CT for identification of residual/recurrent cervical cancer, as well as for localization of distant metastases.

KW - F-FDG

KW - Cervical cancer

KW - Efficacy

KW - PET/CT

KW - Restaging

UR - http://www.scopus.com/inward/record.url?scp=71849091302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71849091302&partnerID=8YFLogxK

U2 - 10.1007/s00259-009-1206-x

DO - 10.1007/s00259-009-1206-x

M3 - Article

C2 - 19585114

AN - SCOPUS:71849091302

VL - 36

SP - 1952

EP - 1959

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

SN - 1619-7070

IS - 12

ER -